Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
ix. lappuse
... FOOD AND DRUGS is composed of nine volumes . The parts in these volumes are arranged in the following order : Parts 1-99 , 100-169 , 170-199 , 200-299 , 300-499 , 500-599 , 600-799 , 800-1299 and 1300 - end . The first eight volumes ...
... FOOD AND DRUGS is composed of nine volumes . The parts in these volumes are arranged in the following order : Parts 1-99 , 100-169 , 170-199 , 200-299 , 300-499 , 500-599 , 600-799 , 800-1299 and 1300 - end . The first eight volumes ...
1. lappuse
... Food and Drugs ( This book contains parts 300 to 499 ) Part CHAPTER I - Food and Drug Administration , Department of Health and Human Services ( Continued ) 300 CROSS REFERENCES : Food Safety and Inspection Service , Department of ...
... Food and Drugs ( This book contains parts 300 to 499 ) Part CHAPTER I - Food and Drug Administration , Department of Health and Human Services ( Continued ) 300 CROSS REFERENCES : Food Safety and Inspection Service , Department of ...
3. lappuse
... FOOD AND DRUG ADMINISTRATION , DEPARTMENT OF HEALTH AND HUMAN SERVICES - Continued ( Parts 300 to 499 ) EDITORIAL NOTE : The Food and Drug Administration published a document at 49 FR 41019 , Oct. 19 , 1984 , establishing July 1 , 1987 ...
... FOOD AND DRUG ADMINISTRATION , DEPARTMENT OF HEALTH AND HUMAN SERVICES - Continued ( Parts 300 to 499 ) EDITORIAL NOTE : The Food and Drug Administration published a document at 49 FR 41019 , Oct. 19 , 1984 , establishing July 1 , 1987 ...
7. lappuse
... Food and Drug Administration's policy in administering the new - drug , antibiotic , and other regulatory provi- sions of the Federal Food , Drug , and Cosmetic Act regarding fixed combina- tion dosage form prescription drugs for humans ...
... Food and Drug Administration's policy in administering the new - drug , antibiotic , and other regulatory provi- sions of the Federal Food , Drug , and Cosmetic Act regarding fixed combina- tion dosage form prescription drugs for humans ...
9. lappuse
... Food and Drugs . ( e ) The term person includes individ- uals , partnerships , corporations , and associations . ( f ) The definitions and interpreta- tions of terms contained in section 201 of the act shall be applicable to such terms ...
... Food and Drugs . ( e ) The term person includes individ- uals , partnerships , corporations , and associations . ( f ) The definitions and interpreta- tions of terms contained in section 201 of the act shall be applicable to such terms ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning